![Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer | Anticancer Research Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/37/1/35/F1.large.jpg)
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer | Anticancer Research
![HDAC inhibitors clinical status. The clinical trials information was... | Download Scientific Diagram HDAC inhibitors clinical status. The clinical trials information was... | Download Scientific Diagram](https://www.researchgate.net/profile/Monish-Makena/publication/331532368/figure/tbl1/AS:733142885351425@1551806293395/HDAC-inhibitors-clinical-status-The-clinical-trials-information-was-obtained-from.png)
HDAC inhibitors clinical status. The clinical trials information was... | Download Scientific Diagram
![Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology](https://www.frontiersin.org/files/MyHome%20Article%20Library/544683/544683_Thumb_400.jpg)
Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology
![From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs | EMBO Molecular Medicine From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/61a5a901-7a73-434a-8ef2-ce0146f3b4bb/emmm201809854-fig-0002-m.jpg)
From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs | EMBO Molecular Medicine
![IJMS | Free Full-Text | HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases | HTML IJMS | Free Full-Text | HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases | HTML](https://www.mdpi.com/ijms/ijms-20-01329/article_deploy/html/images/ijms-20-01329-g001.png)
IJMS | Free Full-Text | HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases | HTML
![Frontiers | Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials | Genetics Frontiers | Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials | Genetics](https://www.frontiersin.org/files/Articles/578011/fgene-11-578011-HTML/image_m/fgene-11-578011-g001.jpg)
Frontiers | Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials | Genetics
![HDAC inhibitors currently under clinical investigation. Various HDAC... | Download Scientific Diagram HDAC inhibitors currently under clinical investigation. Various HDAC... | Download Scientific Diagram](https://www.researchgate.net/profile/Zhiming-Li-5/publication/263862073/figure/tbl1/AS:668858348220418@1536479665050/HDAC-inhibitors-currently-under-clinical-investigation-Various-HDAC-inhibitors-are.png)
HDAC inhibitors currently under clinical investigation. Various HDAC... | Download Scientific Diagram
![Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer - eBioMedicine Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b30c592c-2800-484c-87eb-6a8d8dd62ae8/gr1_lrg.jpg)
Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer - eBioMedicine
![Frontiers | Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma | Cell and Developmental Biology Frontiers | Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/548663/fcell-08-00486-HTML/image_m/fcell-08-00486-g001.jpg)
Frontiers | Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma | Cell and Developmental Biology
![IJMS | Free Full-Text | Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases | HTML IJMS | Free Full-Text | Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases | HTML](https://www.mdpi.com/ijms/ijms-20-01110/article_deploy/html/images/ijms-20-01110-g001-550.jpg)
IJMS | Free Full-Text | Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases | HTML
![Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-019-0095-0/MediaObjects/41392_2019_95_Fig1_HTML.png)
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy
![IJMS | Free Full-Text | Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia | HTML IJMS | Free Full-Text | Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia | HTML](https://www.mdpi.com/ijms/ijms-21-04281/article_deploy/html/images/ijms-21-04281-g001.png)
IJMS | Free Full-Text | Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia | HTML
![BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma | PNAS BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma | PNAS](https://www.pnas.org/cms/10.1073/pnas.1406722111/asset/ce5378fc-9bcc-458c-9978-b145174bc21b/assets/graphic/pnas.1406722111fig08.jpeg)